Intra-Cellular Therapies Inc
(NASDAQ:ITCI)
$48.36
1.37[2.92%]
Last update: 12:54PM (Delayed 15-Minutes)
Get Real Time Here
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Intra-Cellular Therapies Stock (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.

Loading...
Day Range47.350 - 48.76052 Wk Range42.420 - 66.000Open / Close47.350 / -Float / Outstanding82.342M / 94.705M
Vol / Avg.204.554K / 619.387KMkt Cap4.580BP/E-50d Avg. Price51.010
Div / Yield (Forward)- / -%Payout Ratio-Total Float82.342MEPS-3.320
Seeking Alpha - Jan 2, 2023, 1:04PM
Seeking Alpha - Dec 14, 2022, 6:08PM
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 2, 2022, 1:39PM
StockNews - Oct 6, 2022, 10:23AM
Seeking Alpha - Sep 20, 2022, 7:45PM
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.810-0.570 0.2400
REV66.000M71.870M5.870M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Goldman Sachs on Monday, August 22, 2022. The analyst firm set a price target for 49.00 expecting ITCI to rise to within 12 months (a possible 1.32% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $48.36 last updated Today at January 31, 2023 at 5:54 PM UTC.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.